Clincosm LogoSign in Get a demo

Chronic Hepatitis B

Showing 76 - 100 of 400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial in Worldwide (ABI-H0731, SOC NrtI)

Terminated
  • Chronic Hepatitis B
  • Beverly Hills, California
  • +23 more
Mar 22, 2022

Chronic Hepatitis B Trial in Seoul (Tenofovir disoproxil 245mg, Tenofovir disoproxil fumarate 300mg)

Completed
  • Chronic Hepatitis B
  • Tenofovir disoproxil 245mg
  • Tenofovir disoproxil fumarate 300mg
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 21, 2022

Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis

Recruiting
  • Chronic Hepatitis b
  • test of HBV DNA
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an JiaotongUniversity
Mar 28, 2022

Chronic Hepatitis B Trial in Worldwide (VBR, AB-729, SOC NrtI)

Active, not recruiting
  • Chronic Hepatitis B
  • Darlinghurst, New South Wales, Australia
  • +19 more
Mar 16, 2022

Chronic Hepatitis B Trial in Auckland, London (ALG-020572, Placebo)

Active, not recruiting
  • Chronic Hepatitis B
  • Auckland, New Zealand
  • +2 more
Mar 22, 2022

Chronic Hepatitis B Trial in China (ABI-H0731, ETV, Peg-IFNa)

Active, not recruiting
  • Chronic Hepatitis B
  • Beijing, Beijing, China
  • +8 more
Mar 17, 2022

Chronic Hepatitis b Trial in Busan (Tenofovir disoproxil 245mg, Tenofovir disoproxil fumarate 300mg)

Completed
  • Chronic Hepatitis b
  • Tenofovir disoproxil 245mg
  • Tenofovir disoproxil fumarate 300mg
  • Busan, Korea, Republic of
    Dong-A University Hospital
Mar 9, 2022

Chronic Hepatitis B Trial in Hong Kong (Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV

Recruiting
  • Chronic Hepatitis B
  • Stop current treatment (anti-HBV neucleos(t)ides)
  • Keep current treatment (anti-HBV neucleos(t)ides)
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Chronic Hepatitis B Trial in Worldwide (ALG-010133, Placebo)

Terminated
  • Chronic Hepatitis B
  • Guangzhou, Guangdong, China
  • +9 more
Mar 14, 2022

Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)

Not yet recruiting
  • Chronic Hepatitis b
  • Therapeutic hepatitis B vaccine
  • Commercial Hepatitis B vaccine
  • Adelaide, South Australia, Australia
    Flinders University
Mar 7, 2022

Disease Loads and Status of Treatment

Recruiting
  • Chronic Hepatitis B
  • +2 more
  • Prospective serological assays
  • Retrospective serological assays
  • Taipei City, Taiwan
    National Taiwan University Hospital
Feb 28, 2022

Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • Shanghai, Shanghai, China
  • +1 more
Feb 16, 2022

Chronic Hepatitis b Trial (D418 Tab., CKD-388 Tab.)

Not yet recruiting
  • Chronic Hepatitis b
  • D418 Tab.
  • CKD-388 Tab.
  • (no location specified)
Jan 2, 2022

Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)

Active, not recruiting
  • Chronic Hepatitis B
  • Birtinya, Queensland, Australia
  • +21 more
Dec 20, 2021

Chronic Hepatitis b Trial in Daegu, Seoul, Ulsan (Tenofovir Alafenamide)

Recruiting
  • Chronic Hepatitis b
  • Tenofovir Alafenamide
  • Daegu, Korea, Republic of
  • +9 more
Dec 20, 2021

Chronic Hepatitis B Trial in Worldwide (VIR-2218, Placebo)

Completed
Has Results
  • Chronic Hepatitis B
  • Birtinya, Queensland, Australia
  • +13 more
Dec 9, 2021

Chronic Hepatitis B Trial in Tai'an (Metformin & Entecavir, Placebo & Entecavir)

Completed
  • Chronic Hepatitis B
  • Metformin & Entecavir
  • Placebo & Entecavir
  • Tai'an, Shandong, China
    The 960th Hospital of Chinese PLA Joint Logistics Support Force
Nov 23, 2021

Chronic Hepatitis B Trial (Adefovir Dipivoxil)

Completed
  • Chronic Hepatitis B
  • Adefovir Dipivoxil
  • (no location specified)
Nov 5, 2021

Chronic Hepatitis B Trial in Guangzhou (APG-1387 for Injection)

Completed
  • Chronic Hepatitis B
  • APG-1387 for Injection
  • Guangzhou, Guangdong, China
  • +1 more
Nov 5, 2021

Nucleoside Analogues in Preventing Mother-to-child Transmission

Enrolling by invitation
  • Chronic Hepatitis b
  • Women
    • Guanzhou, Guangdong, China
      The 3rd Affiliated Hospital, Guangzhou Medical University
    Nov 2, 2021

    Chronic Hepatitis B Trial in Shanghai (HRS5091)

    Active, not recruiting
    • Chronic Hepatitis B
    • Shanghai, Shanghai, China
      Shanghai Changhai Hospital
    Oct 19, 2021

    CHRONIC HEPATITIS B Trial in Hô` Chi´ Minh (CTH Chronic Hepatitis B)

    Approved for marketing
    • CHRONIC HEPATITIS B
    • CTH Chronic Hepatitis B
    • Hồ Chí Minh, Ho Chi Minh City, Vietnam
      Saigon Biopharma Company Limited
    Oct 6, 2021

    Stopping Antiviral Treatment in Chronic Hepatitis B

    Recruiting
    • Chronic Hepatitis b
    • Hong Kong, Please Select One ..., Hong Kong
      Man Fung Yuen
    Sep 28, 2021

    Chronic Hepatitis B Trial in Worldwide (TAF)

    Completed
    Has Results
    • Chronic Hepatitis B
    • Los Angeles, California
    • +29 more
    Aug 30, 2021

    TAF for 48 Weeks in HBeAg Positive CHB Patients

    Recruiting
    • Chronic Hepatitis B
    • Tenofovir Alafenamide 25 MG [Vemlidy]
    • Shanghai, China
    • +2 more
    Sep 5, 2021